Suarin, Imie Rose S.

HRN: 21-45-65  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/08/2022
CEFUROXIME 1.5GM (VIAL)
06/08/2022
06/08/2022
IV
1.5g
Loading Dose
PROM
Waiting Final Action 
06/08/2022
CEFUROXIME 750MG (VIAL)
06/08/2022
06/11/2022
IV
750mg
Q8
PROM
06/08/2022
CEFUROXIME 500MG (TAB)
06/08/2022
06/14/2022
ORAL
500mg
Q8h
PROM

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: